Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.86 Insider Own10.32% Shs Outstand25.30M Perf Week-3.17%
Market Cap15.70M Forward P/E- EPS next Y-0.83 Insider Trans0.00% Shs Float22.69M Perf Month-1.87%
Income-18.16M PEG- EPS next Q-0.25 Inst Own10.91% Short Float0.48% Perf Quarter65.56%
Sales0.23M P/S68.28 EPS this Y3.89% Inst Trans-3.31% Short Ratio0.47 Perf Half Y89.58%
Book/sh0.29 P/B2.18 EPS next Y4.05% ROA-68.21% Short Interest0.11M Perf Year-0.69%
Cash/sh0.65 P/C0.96 EPS next 5Y- ROE-125.69% 52W Range0.28 - 0.80 Perf YTD66.50%
Dividend Est.- P/FCF- EPS past 5Y58.67% ROI-301.85% 52W High-22.17% Beta1.16
Dividend TTM- Quick Ratio1.93 Sales past 5Y-2.76% Gross Margin92.48% 52W Low125.34% ATR (14)0.04
Dividend Ex-Date- Current Ratio1.93 EPS Y/Y TTM12.27% Oper. Margin-8572.12% RSI (14)48.81 Volatility3.90% 5.88%
Employees17 Debt/Eq0.00 Sales Y/Y TTM0.00% Profit Margin-8033.63% Recom1.00 Target Price6.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q14.05% Payout- Rel Volume0.18 Prev Close0.63
Sales Surprise-6.67% EPS Surprise-2.13% Sales Q/Q0.00% EarningsMay 16 BMO Avg Volume228.91K Price0.62
SMA20-3.88% SMA509.35% SMA20048.86% Trades Volume42,005 Change-1.87%
Date Action Analyst Rating Change Price Target Change
Mar-01-22Initiated Ladenburg Thalmann Buy $7
May-18-21Initiated Guggenheim Buy $4
Mar-01-18Reiterated H.C. Wainwright Buy $6 → $7.50
Jan-17-18Downgrade Maxim Group Buy → Hold
Oct-09-17Initiated H.C. Wainwright Buy $6
Apr-27-17Initiated Laidlaw Buy $10
Jul-01-15Upgrade Piper Jaffray Neutral → Overweight
May-05-15Initiated H.C. Wainwright Buy $6
May-23-24 08:00AM
May-16-24 09:29AM
May-07-24 08:00AM
Apr-02-24 07:15AM
08:00AM Loading…
Mar-08-24 08:00AM
Dec-12-23 08:00AM
Dec-08-23 04:05PM
Nov-28-23 08:00AM
Nov-16-23 08:44AM
Nov-14-23 04:05PM
Nov-07-23 04:05PM
Nov-02-23 10:37AM
Oct-26-23 08:52PM
Oct-24-23 08:00AM
08:00AM Loading…
Oct-19-23 08:00AM
Oct-12-23 08:00AM
Sep-28-23 08:00AM
Sep-06-23 08:00AM
Aug-13-23 05:36AM
Aug-11-23 07:57AM
Aug-10-23 04:05PM
Aug-03-23 04:05PM
Jul-17-23 06:59AM
Jun-14-23 08:00AM
Jun-05-23 08:00AM
May-25-23 08:00AM
May-16-23 06:29AM
May-15-23 05:35PM
08:00AM Loading…
May-12-23 08:00AM
May-11-23 08:00AM
May-08-23 08:00AM
May-04-23 04:05PM
Apr-19-23 09:00AM
Apr-06-23 04:05PM
Mar-23-23 08:00AM
Mar-18-23 02:06AM
Mar-17-23 06:17AM
Mar-16-23 04:04PM
Mar-15-23 08:00AM
Mar-09-23 04:05PM
Mar-07-23 08:00AM
Feb-07-23 11:16AM
Feb-06-23 10:09AM
Feb-01-23 08:00AM
Jan-26-23 08:00AM
Dec-19-22 04:05PM
Dec-07-22 08:00AM
Nov-28-22 08:00AM
Nov-17-22 05:29AM
Nov-14-22 05:25PM
Nov-07-22 04:05PM
Sep-22-22 08:00AM
Sep-12-22 08:00AM
Sep-01-22 08:00AM
Aug-11-22 05:25PM
Aug-04-22 06:35PM
Jun-13-22 08:00AM
May-26-22 05:10PM
May-15-22 08:04AM
May-12-22 10:20AM
May-11-22 04:05PM
May-10-22 05:55PM
May-09-22 06:45PM
May-05-22 07:15PM
May-04-22 04:05PM
May-03-22 01:00PM
Apr-27-22 10:17AM
Mar-31-22 09:51AM
Mar-23-22 08:00AM
Mar-17-22 04:05PM
Mar-10-22 04:05PM
Feb-02-22 08:00AM
Jan-04-22 08:00AM
Dec-13-21 08:00AM
Dec-06-21 08:35AM
Dec-02-21 08:00AM
Nov-22-21 08:00AM
Nov-11-21 04:01PM
Nov-04-21 03:01PM
Oct-01-21 12:35PM
Sep-29-21 08:00AM
Sep-28-21 04:05PM
Sep-24-21 12:13PM
Sep-23-21 04:01PM
Sep-22-21 03:15PM
Sep-20-21 08:00AM
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.